Choose Your language:
- Social bookmarks:
- Testimonials
-
Thank you. I have received my product with no problems and am very pleased
of the bonus. Thank you once again. Shall be ordering in a few weeks.
Read more »
Our billing is certified by:
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Azithromycin linked to increased cardiovascular mortality - Clinical Advisor
- MedPage TodayAzithromycin linked to increased cardiovascular mortalityClinical AdvisorAzithromycin appears to significantly increase patients' risk for sudden cardiac death compared with patients taking no antibiotics, results of an analysis reveal
- Study: Azithromycin bad for heart patients - abc7.com
- abc7
- Zithromax (Azithromycin): FDA Statement on Risk of Cardiovascular Death - Bay Net
- Bay NetZithromax (Azithromycin): FDA Statement on Risk of Cardiovascular DeathBay NetFDA is reviewing the results from this study and will communicate any new information on azithromycin and this study or the potential risk of QT interval prolongation after the agency has completed its review
- Azithromycin May up Chance of Sudden Cardiac Death - Medscape
- Azithromycin May up Chance of Sudden Cardiac DeathMedscapeMay 16, 2012 (Nashville, Tennessee) — During a five-day course of azithromycin, patients had a small, increased risk of sudden cardiac death compared with those receiving amoxicillin or no antibiotics, in an observational study [1]
- Common antibiotic boosts death risk - Health24.com
- Common antibiotic boosts death riskHealth24
